These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24579927)

  • 21. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
    Gehring K; Kozlov G; Yang M; Fakih R
    J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
    Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
    Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein tyrosine phosphatases in cancer: friends and foes!
    Labbé DP; Hardy S; Tremblay ML
    Prog Mol Biol Transl Sci; 2012; 106():253-306. PubMed ID: 22340721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and backbone dynamics of vanadate-bound PRL-3: comparison of 15N nuclear magnetic resonance relaxation profiles of free and vanadate-bound PRL-3.
    Jeong KW; Kang DI; Lee E; Shin A; Jin B; Park YG; Lee CK; Kim EH; Jeon YH; Kim EE; Kim Y
    Biochemistry; 2014 Jul; 53(29):4814-25. PubMed ID: 24983822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
    Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
    Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.
    Skinner AL; Vartia AA; Williams TD; Laurence JS
    Biochemistry; 2009 May; 48(20):4262-72. PubMed ID: 19341304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1H, 15N, 13C resonance assignments of the reduced and active form of human Protein Tyrosine Phosphatase, PRL-1.
    Skinner AL; Laurence JS
    Biomol NMR Assign; 2009 Jun; 3(1):61-5. PubMed ID: 19636948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
    Rubio T; Köhn M
    Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
    Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
    Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
    BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target.
    Ghelli Luserna di Rorà A; Cerchione C; Martinelli G; Simonetti G
    J Hematol Oncol; 2020 Sep; 13(1):126. PubMed ID: 32958072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural insights into molecular function of the metastasis-associated phosphatase PRL-3.
    Kozlov G; Cheng J; Ziomek E; Banville D; Gehring K; Ekiel I
    J Biol Chem; 2004 Mar; 279(12):11882-9. PubMed ID: 14704153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PRL-3: a metastasis-associated phosphatase in search of a function.
    Bessette DC; Wong PC; Pallen CJ
    Cells Tissues Organs; 2007; 185(1-3):232-6. PubMed ID: 17587829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metastasis-associated gene Prl-3 is a p53 target involved in cell-cycle regulation.
    Basak S; Jacobs SB; Krieg AJ; Pathak N; Zeng Q; Kaldis P; Giaccia AJ; Attardi LD
    Mol Cell; 2008 May; 30(3):303-14. PubMed ID: 18471976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of human PRL-3, the phosphatase associated with cancer metastasis.
    Kim KA; Song JS; Jee J; Sheen MR; Lee C; Lee TG; Ro S; Cho JM; Lee W; Yamazaki T; Jeon YH; Cheong C
    FEBS Lett; 2004 May; 565(1-3):181-7. PubMed ID: 15135076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma.
    Semba S; Mizuuchi E; Yokozaki H
    Cancer Sci; 2010 Oct; 101(10):2254-61. PubMed ID: 20860603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.